The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy. It is SITC's mission to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field.
As a SITC member, you will join a vibrant and growing network of research scientists, physician scientists, clinicians, patients, patient advocates, government representatives and industry leaders.
SITC membership terms span January 1 through December 31. Membership dues are paid annually and cover the calendar year.
Become a SITC member today!